External Defibrillators Market Size, Share, Growth, Industry Analysis, Trends and Dynamics, By Types (Automatic Type, Manually Type), By Applications (Pulseless Ventricular Tachycardia, Ventricular Fibrillation), Regional Insights and Forecast to 2035
- Last Updated: 26-October-2026
- Base Year: 2025
- Historical Data: 2021 - 2024
- Region: Global
- Format: PDF
- Report ID: GGI108339
- SKU ID: 30501349
- Pages: 98
Download FREE Sample
External Defibrillators Market Size
The Global External Defibrillators Market size was USD 6019.7 Million in 2025 and is projected to touch USD 6497.05 Million in 2026 and USD 7012.3 Million in 2027 to USD 12916.64 Million by 2035, exhibiting a CAGR of 7.93% during the forecast period 2026-2035.
Demand in the External Defibrillators Market rests on a clinical reality that has not changed: survival chances fall by up to 10% with every minute that passes before a shock is delivered, so device availability and placement matter as much as technical sophistication. Shockable rhythms account for about 20% of out-of-hospital cardiac arrests, which keeps procurement focused on devices that can detect and treat them quickly. Hospitals, emergency medical services, and community programs are widening deployment, while manufacturers compete on ease of use, readiness monitoring, and lifetime ownership cost rather than shock capability alone.
![]()
In the US External Defibrillators Market, public access programs, state-level school and workplace requirements, and large emergency medical services networks create steady replacement and expansion demand. Bystander CPR is attempted in about 40% of out-of-hospital cases, and every additional trained responder raises the likelihood that a nearby device is used, which supports sustained purchasing across schools, gyms, and offices.
Key Findings
- Starting at USD 6497.05 Million in 2026, the global External Defibrillators Market is set to witness notable growth, reaching USD 7012.3 Million in 2027. By 2035, it is projected to reach USD 12916.64 Million. The market is expected to expand at a CAGR of 7.93% throughout the forecast period from 2026 to 2035.
- Demand for external defibrillators is rising due to the growing burden of sudden cardiac arrest, wider public access programs, and replacement of ageing hospital and ambulance fleets. Shockable rhythms account for about 20% of out-of-hospital cardiac arrests, which keeps procurement focused on fast-acting devices.
- External defibrillators are critical to emergency cardiac care, enabling rapid rhythm analysis, guided shock delivery, and early intervention. Survival chances fall by up to 10% with every minute of delay, so device availability and placement are as important as technical sophistication.
- School, workplace, and community mandates are supporting market expansion, with an estimated 33.1% of placements outside hospitals linked to mandated installation. Automatic Type devices hold 58.6% of the market, reflecting demand for simple, guided operation among untrained rescuers.
- North America accounts for 36.4% of the global market, supported by mature emergency medical services and widespread public access programs. Asia-Pacific holds 25.6% and is expanding coverage through infrastructure investment, rising awareness, and growing demand for rugged, low-maintenance units.
A distinctive feature of this market is that purchasing follows regulation, insurance guidance, and community programs as closely as it follows clinical budgets. An estimated 33.1% of placements outside hospitals are linked to mandated installation in schools, transit hubs, and workplaces, which makes unit demand steadier than in most medical device categories.
Product mix also shapes competition. Automatic Type devices account for 58.6% of the market because they reduce hesitation among untrained rescuers, while Manually Type units hold 41.4% on the strength of hospital and ambulance use, where clinicians control energy selection. Buyers increasingly weigh pad shelf life, battery longevity, and software support, since ownership cost is what separates comparable devices after purchase.
![]()
External Defibrillators Market Trends
Connectivity is changing how organizations manage defibrillators after the purchase decision. Devices that report battery status, pad expiry, and self-test results to a central dashboard reduce the silent failures that once made public access programs difficult to audit, and an estimated 15.2% of newly installed units now ship with some form of remote monitoring. Rhythm analysis algorithms have also become faster and more tolerant of motion and noise, which matters during transport and at crowded public events. Manufacturers are pairing hardware with real-time voice and visual coaching for compressions, and program managers increasingly treat that coaching as a selection criterion rather than an optional extra. Service contracts are attached to roughly 34.8% of institutional purchases as software-linked features raise the importance of ongoing support.
Design priorities are shifting toward smaller, lighter, and more rugged units that suit homes, vehicles, and remote worksites. Pediatric capability is moving into mainstream models through attenuated pads and child modes, so schools and sports facilities can standardize on a common device type. Sustainability is gaining weight as well: trade-in and refurbishment programs are appearing in tenders, and environmental criteria now figure in an estimated 7.4% of public procurement evaluations. Hospital buyers are consolidating vendors to align defibrillators with patient monitors and data systems, a pattern that influences about 12.6% of large-facility purchasing decisions, while emerging-market buyers favor low-maintenance units built for unreliable power and limited technical support.
External Defibrillators Market Dynamics
Expanding Public Access and Residential Placement
Untapped placement density is the clearest growth opening. In many countries, fewer than 25% of public venues that would qualify for a device actually have one on site, and smaller commercial buildings, residential communities, rural clinics, and school sports fields remain especially underserved. Vendors that bundle devices with training, device location registration, and automated readiness alerts can turn awareness campaigns into recurring consumable and service business. Insurers and employers are also recognizing the cost of delayed response, and an estimated 19.3% of newly installed devices now go to buildings without prior defibrillator coverage, which creates room for entry-level, low-maintenance models in emerging economies.
Rising Cardiac Arrest Burden and Mandated Access
Cardiovascular disease continues to enlarge the pool of people at risk, and ageing populations raise that exposure further. Adults aged 65 and above account for an estimated 62.7% of sudden cardiac events in developed economies, which pushes hospitals, care homes, and emergency services to keep devices close to patients. Regulation reinforces the pattern, as school, sports, and workplace requirements widen the installed base while units beyond their recommended service life, estimated at 13.5% of the installed fleet, are scheduled for replacement. Together these forces keep demand resilient when capital budgets tighten, because a defibrillator is regarded as safety infrastructure rather than discretionary equipment.
| Market Driver | Impact Rank | Driver Contribution | 2026-2028 | 2029-2031 | 2032-2035 |
|---|---|---|---|---|---|
| Rising incidence of sudden cardiac arrest and ageing populations | High | 3.4% | High | High | Medium |
| Expansion of public access defibrillation programs and mandates | High | 2.9% | High | High | Medium |
| Replacement of ageing hospital and emergency service devices | Medium | 2.3% | Medium | High | Medium |
| Connected, AI-guided, and easier-to-use device technology | Medium | 1.7% | Medium | High | High |
| Training and awareness growth in emerging economies | Low | 0.8% | Low | Medium | Medium |
| Others | Lowest | 0.4% | Low | Low | Low |
| Total Driver Contribution | 11.5% |
RESTRAINTS
"High ownership costs and readiness gaps"
Price remains a barrier for schools, small businesses, and public agencies in lower-income regions. Beyond the purchase itself, pads and batteries must be replaced on schedule, and these consumables account for about 26.1% of lifetime ownership cost, a figure that surprises many first-time buyers. Funding is another weak point, because community programs that depend on grants often struggle once initial financing ends, and an estimated 12.3% of such programs lapse without a replacement plan. Recalls or safety notices tied to software or battery issues can also interrupt fleet confidence, affecting roughly 6.8% of installed units during a typical correction cycle. Together these factors slow adoption among cost-sensitive buyers and lengthen procurement decisions.
| Market Restraint | Impact Rank | Negative CAGR Impact | 2026-2028 | 2029-2031 | 2032-2035 |
|---|---|---|---|---|---|
| High device, pad, and battery ownership costs | High | -1.6% | High | High | Medium |
| Maintenance lapses, recalls, and regulatory compliance burden | Medium | -1.1% | High | Medium | Medium |
| Funding gaps and limited awareness in lower-income regions | Low | -0.6% | Medium | Low | Low |
| Others | Lowest | -0.27% | Low | Low | Low |
| Total Restraint Impact | -3.57% |
CHALLENGES
"Maintenance discipline and regulatory complexity"
Unmonitored devices are the hidden weakness of public access programs. Inspection checks on community-placed units regularly turn up missing pads, expired batteries, or depleted power, and no amount of awareness helps when a cabinet device fails at the moment of need. On the supply side, premarket approval, quality system obligations, and post-market surveillance extend development timelines, and compliance functions absorb an estimated 14.1% of operating cost for smaller manufacturers. Battery and electrode supply constraints add further pressure, with component price swings influencing about 5.7% of product cost in volatile periods. Vendors that cannot pair dependable hardware with simple readiness tracking risk losing institutional accounts to better-supported competitors.
Segmentation Analysis
The External Defibrillators Market is segmented by type and by application, and the two views explain very different buying behavior. Device selection depends on who is expected to operate it and where it will sit: lay rescuers in public venues use an estimated 46.2% of deployed units, while clinicians in hospitals and ambulances rely on more configurable equipment. Application segmentation follows the cardiac rhythm being treated, which determines algorithm design, energy delivery, and alarm logic. Together, these views show why simplicity drives volume while advanced control supports higher-acuity care settings.
By Type
Automatic Type
Automatic Type devices lead the market with a 58.6% share because they analyze rhythm and guide the rescuer with minimal input, which lowers hesitation among untrained bystanders. Placement in schools, offices, airports, and fitness venues is the main demand source, and an estimated 71.3% of these units are installed in non-hospital settings. Vendors differentiate on shock delivery speed, voice coaching, pad shelf life, and remote readiness reporting, which gives this segment the strongest link to service and consumables revenue streams.
Manually Type
Manually Type units hold a 41.4% share and remain essential where trained clinicians need control over energy selection, synchronization, and monitoring functions. Hospitals, emergency departments, and ambulance services account for about 83.5% of demand in this segment, and purchases are often bundled with patient monitoring and data integration. Because buyers evaluate clinical flexibility, durability, and compatibility with existing protocols, replacement cycles tend to be longer and vendor relationships more entrenched than in the public access segment.
By Application
Pulseless Ventricular Tachycardia
Pulseless Ventricular Tachycardia represents 35.7% of the application mix, and treatment depends on devices that recognize a fast organized rhythm without a detectable pulse and deliver a shock promptly. Rate thresholds are a design variable, since devices must be sensitive enough to treat dangerous tachyarrhythmias yet avoid inappropriate shocks. Hospital and ambulance buyers weigh these programmable detection settings carefully, and an estimated 38.6% of clinical purchasing evaluations focus on rhythm analysis performance for this condition.
Ventricular Fibrillation
Ventricular Fibrillation leads the application mix with a 64.3% share, reflecting its role as the most recognized shockable rhythm in cardiac arrest and the main design target for public access devices. Resuscitation guidance calls for algorithms that detect this rhythm with sensitivity above 90% and specificity above 95%, so performance validation remains a central purchasing criterion. Because early defibrillation changes outcomes more dramatically here than in other rhythms, this application anchors demand for widely distributed, easy-to-use devices.
![]()
External Defibrillators Market Regional Outlook
North America
North America leads with a 36.4% share, supported by mature emergency medical services, widespread public access programs, and strong awareness of cardiac arrest response. The United States contributes roughly 82.3% of regional demand, helped by school and workplace requirements in many states and a large installed base now entering replacement cycles. Buyers in this region place heavy weight on connected readiness monitoring and service contracts, while Canada adds steady demand through provincial public access initiatives and hospital upgrades.
Europe
Europe accounts for a 27.8% share, with demand shaped by national public access policies, citizen responder networks, and structured hospital procurement. Germany, the United Kingdom, France, and Italy together represent an estimated 64.9% of regional activity, and tender-based purchasing places emphasis on lifecycle cost, interoperability, and environmental criteria. Countries with organized volunteer alert systems tend to show higher device utilization, which encourages municipalities to map and expand placement in transport hubs, sports venues, and residential districts.
Asia-Pacific
Asia-Pacific holds a 25.6% share and is the region where public awareness and infrastructure investment are changing fastest. Japan is the most established national market and represents about 29.7% of regional demand, thanks to long-running public placement and strong domestic manufacturing. China, India, South Korea, and Australia are widening coverage in airports, rail networks, and large urban facilities, while price-sensitive buyers in developing economies favor rugged, low-maintenance units suited to varied operating conditions.
Middle East & Africa
Middle East & Africa represents a 10.2% share, with demand concentrated in Gulf economies investing in hospitals, airports, and large public venues. Gulf countries account for an estimated 57.4% of regional purchasing, supported by healthcare modernization programs and growing event and tourism infrastructure. Across Africa, adoption remains uneven because of funding and training limits, though private hospitals and corporate campuses are creating pockets of demand and encouraging vendors to build distribution and service partnerships.
List of Key External Defibrillators Market Companies Profiled
- Philips Healthcare
- BOSTON SCIENTIFIC
- Osatu (Mondragon)
- Zoll
- Physio-Control
- HeartSine Technologies
- ZOLL
- Defibtech
- Nihon Kohden
- GE Healthcare
- Laerdal Medical
- Cardiac Science
Top Companies with Highest Market Share
- Philips Healthcare: holds an estimated 17.8% market share, supported by a broad AED and hospital defibrillator portfolio.
- ZOLL: accounts for an estimated 15.4% market share, driven by strong emergency medical services and hospital relationships.
Investment Analysis and Opportunities
Investment in the External Defibrillators Market is shifting from pure hardware toward connected ecosystems that combine devices, software, training, and managed service. Manufacturers are directing an estimated 22.7% of research budgets toward readiness monitoring, rhythm analysis refinement, and data integration, because recurring service relationships stabilize earnings better than one-time equipment sales. Opportunities are strongest in residential communities, small businesses, and emerging economies, where an estimated 16.5% of qualifying venues still lack any device. Private investors also see value in distribution, maintenance, and program management businesses that help institutions keep large fleets compliant. Buyers that standardize on a vendor for devices and consumables often cut administrative workload, which makes bundled offerings attractive for public agencies and multi-site employers.
New Products Development
New product development is centered on making defibrillators easier to use, easier to maintain, and easier to track. An estimated 27.4% of recent introductions emphasize improved voice and visual coaching, since clearer guidance helps untrained rescuers act with confidence under stress. Longer-life pads and batteries are another priority, with extended shelf life reducing the consumable burden that makes up a large part of ownership cost. Developers are also adding pediatric modes, rugged enclosures, and wireless self-test reporting, and about 9.8% of new models are designed specifically for vehicles, remote sites, or home use. Hospital-oriented launches focus on monitor integration, data export, and flexible energy control, aligning defibrillators with wider resuscitation workflows.
Recent Developments
- February 2024– Philips Healthcare expands readiness monitoring support for public access programs: The company broadened service and monitoring support around its AED portfolio so program managers can track pad and battery status across multiple sites. Early program feedback pointed to a 31.2% reduction in missed inspections, which strengthens the case for managed service agreements in schools and workplaces within the External Defibrillators Market.
- June 2024– ZOLL strengthens training-integrated AED offerings for institutional buyers: ZOLL placed greater emphasis on devices paired with real-time coaching and training tools aimed at schools, employers, and emergency responders. Buyers evaluating training-linked models reported a 14.9% improvement in responder confidence during drills, supporting wider adoption of guided devices across the External Defibrillators Market.
- October 2024– Physio-Control reinforces hospital and ambulance defibrillator replacement programs: Physio-Control prioritized upgrade pathways for ageing clinical fleets, focusing on monitoring integration and data connectivity. Replacement-driven orders are estimated to represent 21.9% of its institutional activity, highlighting how refresh cycles continue to sustain demand in the External Defibrillators Market.
- March 2025– Defibtech advances lower-maintenance AED designs for community programs: Defibtech highlighted longer-life consumables and simplified self-testing aimed at budget-conscious public access buyers. Extended consumable life can cut replacement frequency by an estimated 18.3%, which addresses a major ownership cost concern across the External Defibrillators Market.
- September 2025– Nihon Kohden deepens integration of defibrillators with patient monitoring systems: Nihon Kohden continued to align defibrillators with monitoring and data platforms used in acute care settings. Hospitals adopting integrated systems report a 10.7% reduction in documentation time during resuscitation events, supporting vendor consolidation trends in the External Defibrillators Market.
Report Coverage
This report examines the External Defibrillators Market through market definition, segmentation, regional analysis, competitive profiling, and an assessment of growth drivers, restraints, opportunities, and challenges. Segmentation covers Automatic Type and Manually Type devices, which hold 58.6% and 41.4% of the market respectively, and applications spanning Pulseless Ventricular Tachycardia at 35.7% and Ventricular Fibrillation at 64.3%. Regional analysis addresses North America, Europe, Asia-Pacific, and Middle East & Africa, with market shares of 36.4%, 27.8%, 25.6%, and 10.2% that together account for the full market. Company profiles include Philips Healthcare, BOSTON SCIENTIFIC, Osatu (Mondragon), Zoll, Physio-Control, HeartSine Technologies, ZOLL, Defibtech, Nihon Kohden, GE Healthcare, Laerdal Medical, and Cardiac Science, with attention to portfolio direction, product development, and commercial positioning. The analysis also considers purchasing behavior, where an estimated 33.1% of non-hospital placements follow mandated installation, and it highlights practical implications for manufacturers, distributors, investors, and institutional buyers planning deployment, replacement, and service strategies.
External Defibrillators Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 6497.05 Million in 2026 |
|
|
Market Size Value By |
USD 12916.64 Million by 2035 |
|
|
Growth Rate |
CAGR of 7.93% from 2026 - 2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Download FREE Sample
Frequently Asked Questions
-
What value is the External Defibrillators Market expected to touch by 2035?
The global External Defibrillators Market is expected to reach USD 12916.64 Million by 2035.
-
What CAGR is the External Defibrillators Market expected to exhibit by 2035?
The External Defibrillators Market is expected to exhibit a CAGR of 7.93% by 2035.
-
Who are the top players in the External Defibrillators Market?
Philips Healthcare, BOSTON SCIENTIFIC, Osatu (Mondragon), Zoll, Physio-Control, HeartSine Technologies, ZOLL, Defibtech, Nihon Kohden, GE Healthcare, Laerdal Medical, Cardiac Science
-
What was the value of the External Defibrillators Market in 2025?
In 2025, the External Defibrillators Market value stood at USD 6019.7 Million.
About the Author(s):
This report was authored by the Healthcare Research Team at Global Growth Insights. The team specializes in pharmaceuticals, biotechnology, medical devices, diagnostics, digital health, healthcare services, and life sciences. Their expertise includes market sizing, regulatory analysis, competitive benchmarking, and healthcare trend forecasting to support strategic investment and business growth.
Our Clients
Download FREE Sample